Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
about
A Mathematical Model of Idiopathic Pulmonary Fibrosis.The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis.Anti-TNFα therapy in inflammatory lung diseases.Factors Promoting Development of Fibrosis in Crohn's Disease.Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis.Pirfenidone-induced photo-allergic reaction in a patient with idiopathic pulmonary fibrosis.Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine.Effect of pirfenidone on wound healing in lung transplant patients.Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathwayDevelopment of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling
P2860
Q35766783-CD5D2C50-8EED-4D09-A54E-1E3CAC19F67DQ35978150-EB71B834-FA3B-4097-ADF9-CE7D0CAA4A5CQ39392448-622A8D8B-2810-49C3-965E-30E80148B89BQ39453646-706E6CEE-3AD1-48C0-A10B-BFF1D1401B31Q41089497-BFAAB278-E718-424A-A00D-0BDFAE90FFF9Q48165520-637F02CB-C449-4E5F-A135-FA651132DFCEQ48657993-A8FF7DEA-4BEF-4893-8FF8-4DD8237DCD66Q50792998-E59CE086-43C5-4DC6-A559-213EFFA2470FQ51082089-D113C9B3-AE8F-4B65-88CA-C5B323E9D107Q55339490-8EE4B88E-F708-4C6F-B3A7-30DE4F6461A8Q55605572-79BD2E93-8727-4D8E-A08D-D8DDB1D6F093Q58718304-C2C1160F-030C-4F2D-8A86-85BB8C8C978FQ59291741-575A33AE-FE38-4ACD-87AD-C1692C6C14CD
P2860
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@ast
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@en
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@nl
type
label
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@ast
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@en
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@nl
prefLabel
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@ast
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@en
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@nl
P2093
P2860
P356
P1476
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
@en
P2093
Atsushi Kumanogoh
Kazuyuki Tsujino
Takashi Kijima
Yoshito Takeda
P2860
P304
P356
10.2147/PPA.S37233
P407
P577
2014-01-01T00:00:00Z